March 29 (Reuters) - Biomx Inc PHGE.A :
* BIOMX REPORTS FOURTH QUARTER AND FULL YEAR 2022 FINANCIAL
RESULTS AND PROVIDES BUSINESS UPDATE
* BIOMX INC - CASH RUNWAY THROUGH AT LEAST MID-2024
* BIOMX INC - PATIENT ENROLLMENT CONTINUES IN PART 2 OF
PHASE
1B/2A TRIAL WITH RESULTS EXPECTED IN Q3 OF 2023
* BIOMX INC - ANNOUNCED POSITIVE RESULTS FROM PART 1 OF
ONGOING
PHASE 1B/2A TRIAL OF BX004 FOR TREATMENT OF LUNG INFECTIONS IN
CYSTIC FIBROSIS ("CF")
* BIOMX INC - CASH BALANCE, SHORT-TERM DEPOSITS AND
RESTRICTED
CASH AS OF DECEMBER 31, 2022, WERE $34.3 MILLION
Source text for Eikon: ID:nGNX7bDTxw
Further company coverage: PHGE.A
((Reuters.Briefs@thomsonreuters.com;))